- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
October 16, 2015
Following the recent announcement of new guidelines by WHO, this webinar looked at the implications of treatment for all for HIV prevention programmes.
Speakers included Professor Jens Lundgren, one of the principal investigators of the START study; Dr Meg Doherty, Coordinator of Treatment and Care in the Department of HIV/AIDS at WHO, and Giulio Maria Corbelli, Chair of the European Community Advisory Board (ECAB).
The webinar was chaired by Gus Cairns of EATG.
Speakers
Professor Jens Lundgren
Copenhagen University Hospital
Dr. Meg Doherty
WHO